Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
Do you employ a phrenic nerve dose constraint with conventional fractionation?
E.g. breast or H&N cancers when boosting the supraclav area.
Answer from: Radiation Oncologist at Community Practice
No.
Sign In
or
Register
to read more
14494
Related Questions
What is your recommendation for patients who are on weight loss medications like GLP-1-based therapies while receiving chemoradiation for head and neck cancer?
What is the role for chemo immunotherapy in the up front setting in non-metastatic head & neck cancer outside of clinical trials?
What are your top takeaways in Head & Neck Cancers from ASCO 2025?
How do you counsel patients regarding alcohol consumption following treatment of head and neck cancer?
What alternatives do you recommend for oral dexamethasone solution for HN cancer?
What dose would you use for a plaque brachytherapy for a melanoma involving the iris?
Is there a scenario in which you would consider observation for T4a SCC involving the mandible?
What would your approach be for a locally advanced head and neck cancer diagnosed concurrently with a mid-esophageal cancer?
What is the role of radiation therapy for Kimura's disease of the parotid and neck?
What is the recommended treatment approach for stage III/IVA nasopharyngeal cancer that is p16 negative and EBV positive?